Skye Bioscience, Inc. — Form D

Skye Bioscience, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-03. The offering totals $500K, of which $500K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Douglas S IngramExecutive OfficerCAMBRIDGE, MA
Andrew SchwabDirectorBOSTON, MA
Praveen TyleDirectorEncinitas, CA
Annalisa JenkinsDirectorDallas, TX
Margaret DalesandroDirectorSan Diego, CA
Punit DhillonDirectorSan Diego, CA
Punit DhillonExecutive OfficerSan Diego, CA
Kaitlyn ArsenaultExecutive OfficerSan Diego, CA
Deborah CharychDirectorSan Diego, CA
Paul GraysonDirectorSan Diego, CA
Keith WardDirectorSan Diego, CA
Douglas S IngramDirectorCAMBRIDGE, MA
James L HeppellDirectorSan Diego, CA
Punit S DhillonDirectorSan Diego, CA
Douglas A CesarioExecutive OfficerLong Beach, CA
Avtar L DhillonDirectorLong Beach, CA
Brian S MurphyDirectorLong Beach, CA
Brian S MurphyExecutive OfficerLong Beach, CA
Elizabeth M BereczExecutive OfficerCosta Mesa, CA
Jim S HeppellDirectorCosta Mesa, CA
Gerald W McLaughlinDirectorCosta Mesa, CA
Cosmas N LykosDirectorCosta Mesa, CA
Cosmas N LykosExecutive OfficerCosta Mesa, CA
Thomas A GeorgeDirectorCosta Mesa, CA
John B HollisterDirectorScottsdale, AZ

Other filings by this issuer (16)

Showing 15 of 16 filings.

FiledFormOfferingSold
2024-03-27D$40.0M$40.0M
2024-02-12D$50.0M$50.0M
2023-08-29D$62.3M$62.3M
2018-11-15D$32.5M$2.0M
2018-02-23D/A$8.6M$4.2M
2018-01-25D$6.8M$2.4M
2017-11-14D$2.0M$2.0M
2017-01-13D$1.5M$1.2M
2015-08-27D$5.0M$5.0M
2015-04-15D$2.5M$625K
2015-01-09D$725K$725K
2014-11-13D
2013-01-22D/A$25K$25K
2012-11-08D
2012-11-07D/A$9K$9K

More